These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10682995)

  • 1. Endpoints for homocysteine-lowering trials.
    Bostom AG; Garber C
    Lancet; 2000 Feb; 355(9203):511-2. PubMed ID: 10682995
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and the heart.
    Turner SL; Bechtel GA
    Adv Nurse Pract; 1999 Mar; 7(3):71-3. PubMed ID: 10373803
    [No Abstract]   [Full Text] [Related]  

  • 4. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and coronary risk.
    Seshadri N; Robinson K
    Curr Cardiol Rep; 1999 Jul; 1(2):91-8. PubMed ID: 10980826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent stroke in a young patient with celiac disease and hyperhomocysteinemia.
    Gefel D; Doncheva M; Ben-Valid E; el Wahab-Daraushe A; Lugassy G; Sela BA
    Isr Med Assoc J; 2002 Mar; 4(3):222-3. PubMed ID: 11908270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lowering plasma homocysteine reduce vascular disease risk?
    Miller JW
    Nutr Rev; 2001 Jul; 59(7):242-4. PubMed ID: 11475450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    Schnyder G; Roffi M; Pin R; Flammer Y; Lange H; Eberli FR; Meier B; Turi ZG; Hess OM
    N Engl J Med; 2001 Nov; 345(22):1593-600. PubMed ID: 11757505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score.
    Vermeulen EG; van Engeland MI; Visser FC; Stehouwer CD; Twisk JW; van Campen CM; Rauwerda JA
    Int J Cardiol; 2004 Feb; 93(2-3):323-4. PubMed ID: 14975573
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
    Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
    Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and folic acid: implications for pregnancy.
    Daly S; Cotter A; Molloy AE; Scott J
    Semin Vasc Med; 2005 May; 5(2):190-200. PubMed ID: 16047271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
    Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
    J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homocysteine and coronary artery disease].
    Aro A
    Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperhomocyst(e)inemia as a risk factor after renal transplantation.
    Ducloux D; Motte G; Massy ZA
    Ann Transplant; 2001; 6(4):40-2. PubMed ID: 12035457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
    Stehouwer DA
    Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.